Alvotech GAAP EPS of -$1.24, revenue of $15.9M Source link
Alvotech GAAP EPS of -$1.24, revenue of $15.9M Source link
Alvotech, Bioventure get approval for Humira biosimilar in Saudi Arabia Source link
Alvotech completes $59.7M private offering of convertible bonds Source link
Alvotech shares move to Nasdaq Iceland Main Market Source link
Alvotech GAAP EPS of -$1.00, revenue of $59.2M Source link